Not a hype cycle
Risk ratios (RR) for cardiovascular death estimates according to direct (DPP-4 inhibitors, GLP-1RA and SGLT-2 inhibitors against placebo) and indirect (DPP-4 inhibitors vs GLP-1RA or SGLT-2 inhibitors, and GLP-1RA vs SGLT-2 inhibitors) comparisons
For each parameter, the mean difference or ratio of means was calculated
Insurance Coverage and Cost of GLP-1 Medications Insurance coverage for GLP-1 medications can vary widely depending on the specific medication and your insurance plan
Despite all major review articles highlighting GLP-1 as an incretin hormone [18], meal-test studies and studies using GLP-1 analogues actually show the opposite
In type 1 diabetes mellitus, DKD typically manifests as diabetic glomerulopathy, characterized by thickening of the glomerular basement membrane, mesangial matrix expansion, and hyalinosis affecting both afferent and efferent arterioles [21,22]